Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Status:
Recruiting
Trial end date:
2025-11-15
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce
low back and leg pain. The participants will be 18 to 80 years old, healthy with newly
occurring back or leg pain. The main question aims to compare a group taking active treatment
and a group taking a look-alike substance containing no active treatment. All participants
will answer questions on Day 1, before treatment, and on 7-day after treatment, about:
- Amount and quality of pain
- Interference with physical activity
- Interference with sleep